At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
Take Heart: Low T Treatment Didn't Hurt Arteries
More and more men are receiving testosterone treatment as they age, leading to more and more questions about the benefits and risks of this practice. One such question might have just gotten an answer.
In Low T Patients, an Unexpected Hormone Therapy Benefit
Older men with low T may wind up reaping some unexpected benefits from hormone therapy.
How Even Borderline Low T Might Affect Your Health
Even if you're close to having low testosterone but not quite there, you still might encounter some related health problems.
Testosterone Therapy May Not Hurt Your Ticker
Men who need testosterone therapy may be able to breathe a sigh of relief. New evidence suggests that testosterone therapy may not increase the risk of heart problems.
Testosterone and Men’s Health: Controversy Unraveled
Testosterone treatment — what’s a guy to do? This therapy is under heavy scrutiny because of fears that it may increase heart disease risks. Those fears, however, may be unfounded.
Low T May Worsen Heart Risks in Men With Diabetes
Diabetes and low testosterone may each increase the risk of heart disease. Having both may push that risk even higher.
FDA Panel Wants to Limit Testosterone Rx Use
Concerned about a potential increased risk of heart-related conditions, a US Food and Drug Administration (FDA) committee has suggested limits to the use of testosterone replacement therapy (TRT).
Testosterone Therapy Not Linked to Heart Attack
As men age, their bodies may start to produce less testosterone. In some cases, men may need to use testosterone therapy to prevent certain health problems. However, some research suggests that testosterone therapy could raise the risk for heart attack.
FDA Requiring Warning of Blood Clots on Testosterone Products
The U.S. Food and Drug Administration (FDA) is requiring manufacturers to include a general warning in the drug labeling of all approved testosterone products about the risk of blood clots in the veins.
Nasal Gel for Low Testosterone Gets FDA Approval
Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that the United States Food and Drug Administration (FDA) has approved Natesto™ (testosterone), formerly CompleoTRT™, to treat men with low testosterone.